The little stock that could. It wasn't long ago that CTIC was trading around $0.05, currently (5/11/09 12:30p) is now trading over $1.45. The stock recently broke the $1.00 plane and is not looking back. CTIC has become a benchmark for all penny stocks.
The company Cell Therapeutics has made great strides in cutting costs, and announced recently they plan to break even before the end of Q4. Currently they have the drug Pixantrone which is now available in Europe on a named patient basis. It is used for the treatment of aggressive non-Hodgkin's lymphoma (NHL) that has relapsed, without the use of chemotherapy. The same drug is should have the FDA's approval by December 2009.
they have a positive outlook for most of the many meds they offer and they have the production plant in italy where they will produce them cheaply many bioteck firms are moving out of u s a because of very high cost of production and ctic is already there and ready to go !